Stockscreener 앱 받기
35.31
1.64%
-0.59
시간 외 거래:
35.31
전일 마감가:
$35.90
열려 있는:
$35.92
하루 거래량:
398.42K
Relative Volume:
0.73
시가총액:
$1.75B
수익:
$447.57M
순이익/손실:
$-38.92M
주가수익비율:
-42.54
EPS:
-0.83
순현금흐름:
$-1.15M
1주 성능:
+2.62%
1개월 성능:
+11.63%
6개월 성능:
-13.88%
1년 성능:
+64.31%
1일 변동 폭
$35.16
$36.44
1주일 범위
$34.51
$37.80
52주 변동 폭
$20.44
$43.11
Atricure Inc Stock (ATRC) Company Profile
명칭
Atricure Inc
전화
513-755-4100
주소
7555 INNOVATION WAY, MASON, OH
ATRC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
35.31 | 1.82B | 447.57M | -38.92M | -1.15M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
470.08 | 169.94B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
193.50 | 49.41B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
283.90 | 41.12B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
85.75 | 41.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
240.98 | 17.06B | 2.90B | 467.20M | 306.90M | 6.37 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 재개 | JP Morgan | Overweight |
| 2024-04-23 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-29 | 개시 | UBS | Buy |
| 2021-08-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 재확인 | Needham | Buy |
| 2020-11-06 | 재확인 | Needham | Buy |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-24 | 재확인 | Needham | Buy |
| 2019-08-13 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | 개시 | JP Morgan | Overweight |
| 2018-10-04 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Stifel | Buy |
| 2018-06-18 | 재확인 | Needham | Buy |
| 2018-04-27 | 재확인 | Needham | Buy |
| 2018-01-16 | 재확인 | Needham | Buy |
| 2017-11-02 | 재확인 | Needham | Buy |
| 2017-07-28 | 재확인 | Needham | Buy |
| 2017-05-30 | 재개 | Piper Jaffray | Overweight |
| 2016-06-30 | 재개 | JMP Securities | Mkt Outperform |
| 2015-10-28 | 재확인 | Needham | Buy |
| 2015-10-06 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-06 | 재확인 | Needham | Buy |
모두보기
Atricure Inc 주식(ATRC)의 최신 뉴스
AtriCure Inc. stock prediction for this weekFree AI Screening for Swing Trade Picks - Newser
Using Bollinger Bands to evaluate AtriCure Inc.Real-Time Entry Signals for Top Stocks - Newser
What makes AtriCure Inc. stock price move sharplySwing Gain Strategy with Entry Forecast - Newser
Visual analytics tools that track AtriCure Inc. performanceEarnings Report Summary with Market Impact - Newser
Atricure Director Makes a Significant Stock Sale! - TipRanks
What technical models suggest about AtriCure Inc.’s comebackOversold Opportunity Scanner with RSI Data - Newser
AtriCure (ATRC) Q2 2025 Earnings Call Transcript - Mitrade
Atricure’s CSO Makes a Strategic Stock Move! - TipRanks
How AtriCure Inc. stock performs during market volatilityPredictive Screener for Daily Trade Watch - Newser
AtriCure CSO Doraiswamy sells $91k in stock By Investing.com - Investing.com Australia
AtriCure CSO Doraiswamy sells $91k in stock - Investing.com
Candlestick signals on AtriCure Inc. stock todayFree Technical Entry Strategy for Beginners - Newser
A Quick Look at Today's Ratings for AtriCure(ATRC.US), With a Forecast Between $42 to $60 - 富途牛牛
Eighteen-Month LeAAPS Trial Enrollment Completed - Medical Product Outsourcing
Building trade automation scripts for AtriCure Inc.Momentum-Based Prediction for Quick Returns - Newser
Wall Street Zen Upgrades AtriCure (NASDAQ:ATRC) to Buy - Defense World
Why AtriCure Inc. stock attracts strong analyst attentionReal Trader Watchlist with Entry Targets - Newser
What drives AtriCure Inc. stock priceMaximize gains with professional stock picks - Jammu Links News
When is AtriCure Inc. stock expected to show significant growthAccelerated investment success - Jammu Links News
What catalysts could drive AtriCure Inc. stock higher in 2025Powerful profit generation - Jammu Links News
How many analysts rate AtriCure Inc. as a “Buy”Capitalize on emerging market sectors - Jammu Links News
AtriCure Inc. Stock Analysis and ForecastTriple-digit wealth increases - Jammu Links News
How strong is AtriCure Inc. company’s balance sheetAchieve consistent double-digit growth - Jammu Links News
What are the latest earnings results for AtriCure Inc.Consistent triple returns - Jammu Links News
Is AtriCure Inc. a good long term investmentBuild wealth with proven stock investing tactics - Jammu Links News
What is the dividend policy of AtriCure Inc. stockUnlock powerful trading tools for investors - Jammu Links News
What are AtriCure Inc. company’s key revenue driversCapitalize on emerging market sectors - Jammu Links News
How volatile is AtriCure Inc. stock compared to the marketSuperior return velocity - Jammu Links News
What is the risk reward ratio of investing in AtriCure Inc. stockAchieve rapid portfolio growth with expert help - Jammu Links News
Bollinger Bands Show Potential Breakout in AtriCure Inc.Watchlist for Low Risk High Return Stocks Updated - metal.it
Can AtriCure Inc. Escape Recent Bear ChannelReal Profit Trade Plan Suggestions Shared Widely - metal.it
AtriCure Rings the Opening Bell - Nasdaq
AtriCure, Inc. (NASDAQ:ATRC) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - simplywall.st
AtriCure Reports Strong Q2 Earnings with Record Growth - The Globe and Mail
Is AtriCure Inc. a growth stock or a value stockChart Pattern Updates With High Returns - Jammu Links News
AtriCure 2025 Q2 Earnings Beats Expectations with 22.7% Net Income Improvement - AInvest
AtriCure, Inc. (NASDAQ:ATRC) Q2 2025 Earnings Call Transcript - Insider Monkey
AtriCure Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Envestnet Asset Management Inc. Boosts Holdings in AtriCure, Inc. (NASDAQ:ATRC) - Defense World
AtriCure, Inc. SEC 10-Q Report - TradingView
Numerous AtriCure Insiders Sold Stock: Not A Positive Omen - simplywall.st
Needham raises AtriCure stock price target to $45 on strong Q2 results - Investing.com Canada
Needham raises AtriCure stock price target to $45 on strong Q2 results By Investing.com - Investing.com South Africa
AtriCure stock price target raised to $53 from $51 at Canaccord Genuity - Investing.com Canada
AtriCure stock price target raised to $45 from $44 at Needham - Investing.com Australia
AtriCure Stock Soars 10.4% on Strong Q2 Revenue Growth - AInvest
Why LendingClub Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket - Benzinga
JMP reiterates Market Outperform rating on AtriCure stock after strong Q2 - Investing.com Australia
Atricure Inc (ATRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
자본화:
|
볼륨(24시간):